Shire plc Total Voting Rights

TIDMSHP 
 
 
 
   Total Voting Rights 
 
   January 2, 2019 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in 
accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") 
Disclosure Guidance and Transparency Rules, notifies the market of the 
following: 
 
   As at December 31, 2018, the Company's issued ordinary share capital 
comprised 925,477,681 ordinary shares of 5 pence each with voting rights 
and a further 7,357,283 ordinary shares held in treasury. 
 
   Therefore, the total number of voting rights in the Company is 
918,120,398. This is the figure which should be used by shareholders as 
the denominator for the calculations by which they will determine if 
they are required to notify their interest in, or a change to their 
interest in, the Company under the FCA's Disclosure Guidance and 
Transparency Rules. 
 
   Sarah Rixon 
 
   Senior Company Secretarial Assistant 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Christoph Brackmann   [e-mail]   [phone] 
Sun Kim               [e-mail]                [phone] 
Scott Burrows         [e-mail]          [phone] 
 
Media 
Katie Joyce           [e-mail]                 [phone] 
 
 
 
   NOTES TO EDITORS 
 
   About Shire 
 
   Shire is the global biotechnology leader serving patients with rare 
diseases and specialized conditions. We seek to push boundaries through 
discovering and delivering new possibilities for patient communities who 
often have few or no other champions. Relentlessly on the edge of what's 
next, we are serial innovators with a diverse pipeline offering fresh 
thinking and new hope. Serving patients and partnering with healthcare 
communities in over 100 countries, we strive to be part of the entire 
patient journey to enable earlier diagnosis, raise standards of care, 
accelerate access to treatment, and support patients. Our diverse 
portfolio of therapeutic areas includes Immunology, Hematology, Genetic 
Diseases, Neuroscience, Internal Medicine, and Ophthalmics. 
 
 
 
   Championing patients is our call to action - it brings the opportunity - 
and responsibility - to change people's lives. 
 
   www.shire.com 
 
 
 
 

(END) Dow Jones Newswires

January 02, 2019 05:45 ET (10:45 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.